Outcome of high-power short-duration radiofrequency ablation in combination with half-normal saline irrigation for the treatment of atrial fibrillation.


Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
Jan 2022
Historique:
revised: 08 10 2021
received: 05 05 2021
accepted: 07 11 2021
pubmed: 13 11 2021
medline: 23 2 2022
entrez: 12 11 2021
Statut: ppublish

Résumé

Data regarding the use of high-power short-duration (HPSD) radiofrequency (RF) in combination with half-normal saline irrigation for catheter irrigation are limited. This study investigated the safety and efficacy of using HPSD RF ablation in combination with half-normal saline irrigation for the treatment of AF. One hundred consecutive patients with AF underwent RF ablation using HPSD combined with half-normal saline for catheter irrigation. In addition, the following ablation strategies were used: 1 mm tags for the display of ablation lesions on the mapping system, high-frequency jet ventilation (HFJV), low contact force, pacing after ablation to verify areas of noncapture, atrial/ventricular pacing at 500 to 700 ms to aid in catheter stability, use of two skin electrodes to reduce impedance, and postablation adenosine infusion. Power was started at 40 to 45 W and was modulated manually based on impedance changes. The average age of patients was 65.2 years and 70% were male. Forty seven percent had paroxysmal AF and the average CHA Catheter ablation using HPSD RF lesions in combination with half-normal saline irrigation and is safe and effective, and results in high rate of freedom from AF.

Sections du résumé

BACKGROUND BACKGROUND
Data regarding the use of high-power short-duration (HPSD) radiofrequency (RF) in combination with half-normal saline irrigation for catheter irrigation are limited.
OBJECTIVES OBJECTIVE
This study investigated the safety and efficacy of using HPSD RF ablation in combination with half-normal saline irrigation for the treatment of AF.
METHODS METHODS
One hundred consecutive patients with AF underwent RF ablation using HPSD combined with half-normal saline for catheter irrigation. In addition, the following ablation strategies were used: 1 mm tags for the display of ablation lesions on the mapping system, high-frequency jet ventilation (HFJV), low contact force, pacing after ablation to verify areas of noncapture, atrial/ventricular pacing at 500 to 700 ms to aid in catheter stability, use of two skin electrodes to reduce impedance, and postablation adenosine infusion. Power was started at 40 to 45 W and was modulated manually based on impedance changes.
RESULTS RESULTS
The average age of patients was 65.2 years and 70% were male. Forty seven percent had paroxysmal AF and the average CHA
CONCLUSIONS CONCLUSIONS
Catheter ablation using HPSD RF lesions in combination with half-normal saline irrigation and is safe and effective, and results in high rate of freedom from AF.

Identifiants

pubmed: 34766642
doi: 10.1111/pace.14407
doi:

Substances chimiques

Saline Solution 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-49

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation versus antiarrhythmic drug therapy on mortality, stroke, bleeding and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1275-1285.
Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation of atrial fibrillation with heart failure. N Engl J Med. 2018;378:417-427.
Di Biase L, Mohanty P, Santangeli P, et al. Ablation versus amiodarone for treatment of atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133:1637-1644.
Reddy VY, Dukkipati SR, Neuzil P, et al. Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath Contact force ablation catheter study for atrial fibrillation (TOCCASTAR) study. Circulation. 2015;132:907-915.
Winkle RA, Mohanty S, Patrawala RA, et al. Low complication rates using high power (45-50W) for short duration for atrial fibrillation ablations. Heart Rhythm. 2019;16:165-169.
Nguyen DT, Nguyen K, Zheng L, et al. Effect of environmental impedance surrounding a radiofrequency ablation catheter electrode on lesion characteristics. J Cardiovasc Electrophysiol. 2018;28:564-569.
Nguyen DT, Tzou WS, Sandhu A, et al. Prospective multicenter experience with cooled radiofrequency ablation using high impedance irrigant to target deep myocardial substrate refractory to standard ablation. JACC Clin Electrophysiol. 2018;4:1176-1185.
Roka A, Heist EK, Refaat M, Ruskin J, Mansour M. Novel technique to prevent phrenic nerve injury during pulmonary vein isolation using preprocedural imaging. J Cardiovasc Electrophysiol. 2015;26:1057-1062.
Santangeli P, Marchlinski FE. Techniques for the provocation, localization and ablation of non-pulmonary vein triggers for atrial fibrillation. Heart Rhythm. 2017;14:1087-1096.
Rozen G, Ptaszek LM, Zilberman I, et al. Safety and efficacy of delivering high-power short-duration radiofrequency ablation lesions utilizing a novel temperature sensing technology. Europace. 2018;20:f444-f450.
Bhaskaran A, Chik W, Pouliopoulos J, et al. Five seconds of 50-60 W radiofrequency atrial ablations were transmural and safe: an in vitro mechanistic assessment and force-controlled in vivo validation. Europace. 2017;19:8740-8780.
Vassallo F, Cunha C, Serpa E, et al. Comparison of high-power short-duration ablation of atrial fibrillation using a contact force-sensing catheter and conventional technique: initial results. J Cardiovasc Electrophysiol. 2019;30:1877-1883.
Haines DE, Verow AF. Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium. Circulation. 1990;82:1034-1038.
Nguyen DT, Olson M, Zheng L, Braham W, Moss JD, Sauer WH. Effect of irrigant characteristics on lesion formation after radiofrequency energy delivery using ablation catheter with actively cooled tips. J Cardiovasc Electrophysiol. 2015;26:792-798.
Irastorza RM, d'Avila A, Berjano E. Thermal latency adds to lesion depth after application of high-power short-duration radiofrequency energy: results of a computer-modeling study. J Cardiovasc Electrophysiol. 2018;29:322-327.
Piorkowski C, Eitel C, Rolf S, et al. Steerable versus non steerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol. 2011;4:157-165.
Sivasambu B, Hakim JB, Barodka V, et al. Initiation of a high frequency jet ventilation strategy for catheter ablation for atrial fibrillation: safety and outcomes data. JACC Clin Electrophysiol. 2018;4:1519-1525.
Macle L, Khairy P, Weerasooriya R, et al. Adenosine-guided pulmonary isolation for the treatment of paroxysmal atrial fibrillation: an international, multicenter, randomised superiority trial. Lancet. 2015;386:672-679.
Kumar S, Mortan JB, Halloran K, et al. Effect of respiration on catheter-tissue contact force during ablation of atrial arrhythmias. Heart Rhythm. 2012;9:1041-1047.
Steven D, Reddy VY, Inada K, Robert-Thomson KC, Michaud GF. Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation. Heart Rhythm. 2010;7:323-330.
Santangeli P, Zado ES, Hutchinson MD, et al. Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm. 2016;13:374-382.
Cutler MJ, Johnson J, Abozguia K, et al. Impact of voltage mapping to guide whether to perform ablation of the posterior wall in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27:13-21.
Della Rocca DG, Mohanty S, Mohanty P, et al. Long-term outcomes of catheter ablation in patients with longstanding persistent atrial fibrillation lasting less than 2 years. J Cardiovasc Electrophysiol. 2018;29:1607-1615.
Zhao Y, Di Biase L, Trivedi C, Elayi C, Burkhardt D, Natale A. Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Heart Rhythm. 2016;13:141-149.
Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol. 2016;68:1929-1940.
Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58:2225-2232.
Lim HS, Hocini M, Dubois R, et al. Complexity and distribution of drivers in relation to duration of persistent atrial fibrillation. J Am Coll Cardiol. 2017;69:1257-1269.
Suenari K, Chen YC, Kao YH, et al. Discrepant electrophysiological characteristics and calcium homeostasis of left anterior and posterior myocyctes. J Cardiovascular Electrophysiol. 2012;23:271-279.
Rozen G, Ptaszek L, Zilberman I, et al. Prediction of radiofrequency ablation lesion formation using a novel temperature sensing technology incorporated in a force sensing catheter. Heart Rhythm. 2017;14:248-254.
Lesham E, Zilberman I, Tschabrunn CM, et al. High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization. JACC Clin Electrophysiol. 2018;4:467-479.

Auteurs

Abhishek Maan (A)

Cardiac Arrhythmia Unit, Heart Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

Weeranun D Bode (WD)

Cardiac Arrhythmia Unit, Heart Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

E Kevin Heist (EK)

Cardiac Arrhythmia Unit, Heart Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

Grace Ha (G)

Cardiac Arrhythmia Unit, Heart Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

Anthony Carnicelli (A)

Duke University Hospital/Duke Clinical Research Institute, Durham, North Carolina, USA.

Kathryn Slattery (K)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Michael Fitzsimons (M)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Jeremy Ruskin (J)

Cardiac Arrhythmia Unit, Heart Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

Moussa Mansour (M)

Cardiac Arrhythmia Unit, Heart Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH